NEW GOVERNMENT
COMMENTARY
INTERVIEWS
SPECIALS
CHAT
ARCHIVES
SEARCH REDIFF

Ranbaxy to focus on US, China for global market-share

Pharma and healthcare giant Ranbaxy Laboratories Limited has chalked out its global plans to capture global market shares by way of acquisitions and strategic alliances with its global partner in the near future.

Unveiling the company's global plans in Bombay today, Ranbaxy managing director D S Brar today said that the company would concentrate on the USA and China for increasing its global market share. It will introduce value-added products in the US markets, enter into over-the-counter segment in China and come out with new brand marketing in the UK by year 2000, Brar said.

''Although most of the pharma companies are pulling out of China, Ranbaxy will continue stay in China and even will tie up with Chinese companies very soon,'' he revealed.

Currently the company's global revenue stood at $ 460 million which it would like to take up to $ 1 billion by year 2004, he said.

Ranbaxy had posted a net profit of Rs 7.79 billion during the first half of the 1999-2000 as against Rs 5.04 billion in the corresponding period a year ago. The company has posted a net sales of Rs 40.97 billion as against Rs 41.63 billion in the corresponding period a year ago.

The company had introduced various new products during the last four years. Besides, the USA and China, the company would also shift its focus on Brazil, West Europe, Russia, in the coming year.

It is looking for great future in Brazil following a passage of a new law by the government there. It will try to increase growth in business in West Europe through strategic alliances and plans to expand its presence in Europe, Brar said.

UNI

Business